The GFRA1 methylation was significantly lower in CRC primary tumors with invasion, indicated that GFRA1 gene regions has the potential as a methylation biomarker for diagnosis and prediction of highly metastatic CRC. Here, GFRA1 is linked to colorectal carcinoma.